At Heart Rhythm 2012, Dr. Albert Waldo shared with StopAfib.org’s Mellanie True Hills about why aspirin should no longer be used for the prevention of stroke in atrial fibrillation. Dr. Waldo noted that many global afib guidelines have been revised, or soon will be, to remove aspirin as a recommended atrial fibrillation stroke prevention treatment. …
Read MoreCategory Archives: Anticoagulation
At the American College of Cardiology meeting last week, I discovered a neat project being tackled by Alere, the sponsor of PTINR.com, which is a web site we highly recommend for those taking Coumadin or warfarin. If you take warfarin or Coumadin, you know that you have to keep your vitamin K intake consistent, but …
Read MoreIn this interview, Dr. Daniel Singer updates us on the new anticoagulants for atrial fibrillation stroke prevention that he presented about at Boston Atrial Fibrillation Symposium. He provided an update on rivaroxaban (Xarelto), apixaban (Eliquis), dabigatran (Pradaxa), and edoxaban, and mentioned that all were better than warfarin (Coumadin) in preventing intracranial bleeding (bleeding in the …
Read MoreAt Boston Atrial Fibrillation Symposium 2012, Dr. Hugh Calkins, electrophysiologist at Johns Hopkins, presented the new 2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation, which will replace the original guidelines that were published in 2007. Instead of simply rewriting sections that have changed, the writing committee, which was made up …
Read MoreDr. John Mandrola, a cardiac electrophysiologist in Louisville, Kentucky, who blogs at Dr. John M, live-blogged the 2012 Boston Atrial Fibrillation Symposium. He has given us permission to reprint his blog posts for the afib community. You will find them here: Recap of Boston Atrial Fibrillation Symposium 2012 – Guest Posts by Dr. John Mandrola …
Read MoreIn follow up to our announcement yesterday of the Top Ten Atrial Fibrillation Videos of 2011, StopAfib.org now unveils the Top Ten Atrial Fibrillation Articles of 2011. Major topics of interest to the atrial fibrillation patient community this year were afib stroke prevention and the CHADS2 and CHA2DS2-VASc scoring tools that determine the need for …
Read MoreStopAfib.org has announced the Top Ten Atrial Fibrillation Videos of 2011. Afib stroke prevention again topped the list, with stories about warfarin (Coumadin), alternatives such as dabigatran (Pradaxa) and rivaroxaban (Xarelto), and the CHADS2 and CHA2DS2-VASc scoring tools for determining whether anticoagulants are needed. Other popular topics included sleep apnea, catheter ablation, and maze procedures (surgical …
Read MoreA recent New England Journal of Medicine article reported on the results of the ARISTOTLE trial comparing the effectiveness of apixaban and warfarin for atrial fibrillation stroke prevention. Apixaban was shown to be superior to warfarin in preventing afib strokes. Learn more about the results of this trial at: Apixaban Superior to Warfarin for Atrial …
Read MoreThe US Food and Drug Administration has approved Xarelto (rivaroxaban) to reduce stroke risk in those with non-valvular atrial fibrillation (afib unrelated to heart valve problems). Xarelto is now the second oral alternative to warfarin (Coumadin) and offers an option for those unable to take warfarin or dabigatran. Xarelto is the first once-a-day alternative to …
Read MoreIn this important video interview at Venice Arrhythmias, Professor Gregory Lip discusses the importance of the CHA2DS2-VASc scoring tool for predicting atrial fibrillation stroke risk and why aspirin is not appropriate for preventing strokes. Watch the video at: Professor Gregory Lip Discusses CHA2DS2-VASc Tool for Predicting Stroke Risk in Atrial Fibrillation — Video
Read More